INTECH Investment Management’s Veracyte VCYT Stock Holding History

INTECH Investment Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Buy	21,537 +1,262	+6%	+$52.9K	0.01%	924
2026 Q1	$653K	Sell	20,275 -9,318	-31%	-$345K	0.01%	1213
2025 Q4	$1.25M	Hold	29,593	–	–	0.01%	997
2025 Q3	$1.02M	Sell	29,593 -3,015	-9%	-$86.5K	0.01%	1155
2025 Q2	$881K	Sell	32,608 -10,154	-24%	-$294K	0.01%	1272
2025 Q1	$1.27M	Buy	42,762 +15,017	+54%	+$572K	0.01%	1048
2024 Q4	$1.1M	Buy	27,745 +6,516	+31%	+$247K	0.01%	1072
2024 Q3	$723K	Buy	+21,229	New	+$597K	0.01%	1002

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

INTECH Investment Management's VCYT Position: Q2 2026 in Review

INTECH Investment Management increased its Veracyte (VCYT) stake by 6.2% in Q2 2026, buying an estimated $52.9K and bringing the position to 21,537 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #924.

INTECH Investment Management first reported a position in VCYT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.27M in Q1 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

INTECH Investment Management held 21,537 shares of Veracyte worth $1.26M as of Q2 2026.
INTECH Investment Management bought 1,262 Veracyte shares in Q2 2026, an estimated $52.9K.
Veracyte made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #924 holding.
INTECH Investment Management first reported a position in Veracyte in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Veracyte position peaked at $1.27M in Q1 2025.
370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.